For: | Kontogianni-Katsarou K, Lariou C, Tsompanaki E, Vourlakou C, Kairi-Vassilatou E, Mastoris C, Pantazi G, Kondi-Pafiti A. KIT-negative gastrointestinal stromal tumors with a long term follow-up: A new subgroup does exist. World J Gastroenterol 2007; 13(7): 1098-1102 [PMID: 17373746 DOI: 10.3748/wjg.v13.i7.1098] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i7/1098.htm |
Number | Citing Articles |
1 |
Qinggang Hu, Shanglong Liu, Jianwei Jiang, Chen Zhang, Xiaowei Liu, Qichang Zheng. Potential indicators predict progress after surgical resection of gastrointestinal stromal tumors. Frontiers of Medicine 2012; 6(3): 317 doi: 10.1007/s11684-012-0203-9
|
2 |
Peter Spieler, Matthias Rössle. Nongynecologic Cytopathology. Essentials of Diagnostic Pathology 2012; : 699 doi: 10.1007/978-3-642-24719-4_11
|
3 |
Silvia Calabuig-Fariñas, José Antonio López-Guerrero, Samuel Navarro, Isidro Machado, Andrés Poveda, Antonio Pellín, Antonio Llombart-Bosch. Evaluation of Prognostic Factors and Their Capacity to Predict Biological Behavior in Gastrointestinal Stromal Tumors. International Journal of Surgical Pathology 2011; 19(4): 448 doi: 10.1177/1066896911402327
|
4 |
Michael C. Heinrich, Kouros Owzar, Christopher L. Corless, Donna Hollis, Ernest C. Borden, Christopher D.M. Fletcher, Christopher W. Ryan, Margaret von Mehren, Charles D. Blanke, Cathryn Rankin, Robert S. Benjamin, Vivien H. Bramwell, George D. Demetri, Monica M. Bertagnolli, Jonathan A. Fletcher. Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. Journal of Clinical Oncology 2008; 26(33): 5360 doi: 10.1200/JCO.2008.17.4284
|
5 |
Katerina Kontogianni-Katsarou, Euthimios Dimitriadis, Constantina Lariou, Evi Kairi-Vassilatou, Nikolaos Pandis, Agatha Kondi-Paphiti. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential. World Journal of Gastroenterology 2008; 14(12): 1891-1897 doi: 10.3748/wjg.14.1891
|
6 |
Stefan Duensing, Anette Duensing. Targeted therapies of gastrointestinal stromal tumors (GIST)—The next frontiers. Biochemical Pharmacology 2010; 80(5): 575 doi: 10.1016/j.bcp.2010.04.006
|